Research and development expenses, percentage of net sale
Boston Scientific·Business Segments·2 segments
Breakdown
Segments
MedSurgView metric
CardiovascularView metric
| Segment | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|
| Cardiovascular | 9% | 9.4% | 10.1% | 0.4% | 9.8% |
| MedSurg | 7.5% | 7% | 7.5% | 0.1% | 7.5% |
| Total | 7.5% | 7% | 7.5% | 0.1% | 7.5% |